- Recent Funding
- Investors
- Michael Rabil
Michael Rabil portfolio
Michael Rabil has 1 portfolio company on record at Recent Funding.
About this page
It is an angel investor. Its most recent investment on record is Hone Health's $33M Series A round in January 2025, alongside Shaan Puri, Tribe Capital, Sam Parr and 6 others. That company is in Health and bio.
What Michael Rabil invests in
- Health and bio · 1 · 100%
- Developer tools and cloud · 1 · 100%
How Michael Rabil invests
| Stage | Deals | Capital in rounds |
|---|---|---|
| Series A | 1 100% | $33M |
Michael Rabil portfolio companies
HHone Health$33MSeries A · Jan 2025
| Company | Round with Michael Rabil | Total raised | Latest raise |
|---|---|---|---|
Health and bio |
Series A · $33M | $261M | Nov 19, 2026 Series A |
Most frequent co-investors
TTribe Capital1 shared round · last Jan 28, 2025
- RRepublic capital1 shared round · last Jan 28, 2025
SShaan Puri1 shared round · last Jan 28, 2025
VVibe VC1 shared round · last Jan 28, 2025
- SSam Parr1 shared round · last Jan 28, 2025
NNikita Bier1 shared round · last Jan 28, 2025
- SStephen Dukker1 shared round · last Jan 28, 2025
PPublic1 shared round · last Jan 28, 2025
- PPaul Rabil1 shared round · last Jan 28, 2025
Similar investors
TThomas Wolf14 companies · 7 deals in 12 mo
CCharlie Songhurst18 companies · 5 deals in 12 mo
PPatrick Collison18 companies · 4 deals in 12 mo
DDylan Field24 companies · 4 deals in 12 mo
SScott Belsky39 companies · 6 deals in 12 mo
GGuillermo Rauch41 companies · 3 deals in 12 mo
Investors whose portfolios on Recent Funding center on the same category (Health and bio).
How this is counted
Share is of the 1 round on Recent Funding that name Michael Rabil. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.
Portfolio companies are the companies on Recent Funding with a round that lists Michael Rabil, which is a subset of its real portfolio. API: /api/v1/investors/michael-rabil (get a free API key). More: the most active VC firms and new venture capital funds.